[1] Younossi ZM, Koenig AB, Abdelatif D, et al. Global epidemiology of nonalcoholic fatty liver diseasedmeta-analytic assessment of prevalence, incidence, and outcomes[J]. Hepatology,2016,64:73-84. [2] Bril F, Cusi K. Management of nonalcoholic fatty liver disease in patients with type 2 diabetes: a call to action[J]. Diabetes Care,2017,40:419-430. [3] Dai W, Ye L,Liu A, et al. Prevalence of nonalcoholic fatty liver disease in patients with type 2 diabetes mel-litus: a meta-analysis[J]. Medicine,2017,96:e8179. doi:10.1097/MD.0000000000008179. [4] Bando Y, Kanehara H, Aoki K, et al. The glycated albumin to glycated haemoglobin ratio increases along with the fibrosis stage in non-alcoholic steatohepatitis[J]. Ann clin Biochem,2012,49:387-490. [5] Luo J, Xu L, Li J, et al. Nonalcoholic fatty liver disease as a potential risk factor of cardiovascular disease[J]. Eur J Gastroenterol Hepatol,2015,27:193-199. [6] Targher G, Marchesini G, Byrne CD. Risk of type 2 diabetes in patients with non-alcoholic fatty liver disease: causal association or epiphenomenon[J]. Diabetes Metab,2016,42:142-156. [7] Adams LA, Anstee QM, Tilg H, et al. Nonalcoholic fatty liver disease and its relationship with cardiovascular disease and other extrahepatic diseases[J]. Gut,2017,66:1138-1153. [8] Ballestri S, Zona S, Targher G, et al. Nonalcoholic fatty liver disease is associated with an almost twofold increased risk of incident type 2 diabetes and metabolic syndrome[J]. Gastroenterol Hepatol,2016,31:936-944. [9] Lau JK, Zhang X, Yu J. Anim almodelsof non-alcoholic fatty liver disease:currentperspectives and recent advances[J]. J Pathol,2017,241:36-44. [10] Kinoshita T, Shimoda M, Sanada J, et al. Association of GA/HbA1c ratio and cognitive impairment in subjects with type 2 diabetes mellitus[J]. Diabetes Complications,2016,30:1452-1455. [11] Kazemi-Bajestani SM, Azarpazhooh MR, Ebrahimi M, et al. Serum high sensitivity CRP concentrations predict the presence of carotid artery plaque in individuals without a history of cardiovascular events[J]. Nutr Metab Cardiovasc Dis,2015,25:434-435. [12] Guo K, Zhang L, Lu J, et al. Non-alcoholic fatty liver disease is associated with late but not early atherosclerotic lesions in Chinese inpatients with type 2 diabetes[J]. J Diabetes Complicat,2017,31:80-85. |